Free Trial

Coloplast A/S (OTCMKTS:CLPBY) Stock Crosses Below Fifty Day Moving Average - Here's Why

Coloplast A/S logo with Medical background

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $13.40 and traded as low as $12.80. Coloplast A/S shares last traded at $12.96, with a volume of 40,772 shares.

Coloplast A/S Stock Performance

The firm has a market capitalization of $27.99 billion, a P/E ratio of 39.27, a P/E/G ratio of 3.30 and a beta of -0.02. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.85 and a quick ratio of 0.56. The stock's 50 day moving average is $13.39 and its two-hundred day moving average is $12.87.

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) last released its earnings results on Tuesday, August 20th. The company reported $0.08 earnings per share for the quarter. The firm had revenue of $993.49 million for the quarter. Coloplast A/S had a return on equity of 31.39% and a net margin of 18.89%. As a group, equities analysts anticipate that Coloplast A/S will post 0.34 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

Featured Articles

→ 625,000% Gain (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in Coloplast A/S right now?

Before you consider Coloplast A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Coloplast A/S wasn't on the list.

While Coloplast A/S currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ISRG Stock Surges: AI and Healthcare Innovation at the Core
Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines